Hélène Lasolle, Julien Hadoux, Segolene Hescot, Arnaud Jannin, Yann Godbert, Victor Sarradin, Alexandre Lugat, Patricia Niccoli, Marie-Eve Garcia, Marie Vinches, Mickael Burgy, Cécile Vicier, Pascale Tomasini, Diego Tosi, Sara Calattini, Sylvie Bin, Fabien Subtil, Benoît You, Marie Béguinot. "IMMUNORARE 5 : A national platform of 5 academic phase II trials coordinated by Lyon University Hospital to assess the safety and the efficacy of the immunotherapy with domvanalimab + zimberelimab combination in patients with advanced rare cancers—The Anaplastic Thyroid Carcinomas Cohort.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps2693